CE

The Spectrum Compact instrument.

The firm's target market for the instruments will include existing customers in the forensics and food testing spaces.

Timothy Kupferschmid

OCME's Department of Forensic Biology recently started testing next-generation sequencing for forensic applications.

NEW YORK (GenomeWeb) — DxTerity Diagnostics has begun commercializing blood sample collection products and a multiplex PCR reagent kit.

NEW YORK (GenomeWeb) – PerkinElmer has signed an agreement to serve as the exclusive global distributor for Sebia's Capillarys 2 Neonat Fast system for labs conducting newborn screening.

COLD SPRING HARBOR, NY (GenomeWeb) — By tracing mutations in hypermutable polyguanine repeats located in intergenic regions, researchers have been able to reconstruct the phylogenies of patients' cancers, giving insight into how metastases develop.

NEW YORK, GenomeWeb − Life Technologies has become a partner in two research projects, the Saudi Human Genome Program and the International Barcode of Life (iBOL) project, the company said this week.

NEW YORK (GenomeWeb News) – AB Sciex today announced that it is combining its Eksigent chromatography business with the capillary electrophoresis unit of its fellow Danaher stablemate Beckman Coulter.

The guidelines set reporting standards for researchers using column chromatography, capillary electrophoresis, and gel image informatics and also for commercial affinity reagents like antibodies, which have posed problems in proteomics research due to the lack of information provided by manufacturers.

Life Tech will also seek FDA clearance for its capillary electrophoresis-based sequencing system for clinical diagnostic applications.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.